INTEZ

  • Product Description:

Intez (letrozole) orally administered tablet contains letrozole USP 2.5 mg. Intez works as a nonsteroidal aromatase inhibitor by inhibiting estrogen synthesis.

  • Product Features:

Product Name intez
Generic Name Letrozole USP 2.5 mg
FDA Approved Indications
  • Adjuvant Treatment of Early Breast Cancer
  • Extended Adjuvant Treatment of Early Breast Cancer
  • First and Second-Line Treatment of Advanced Breast Cancer
Packaging Intez 2.5 mg tablets are supplied in alu-alu blister.
Each 30’s box of Intez contains 3X10’s tablets
Prescribing Information intez 2.5 mg (PDF)